Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-2.17	126.42	129.22
Graham Fair Price	-6.16	64.65	68.89
PEG	-815.98	-14.36	-1.57
Price/Book	56.51	15.80	10.10
Price/Cash Flow	142.94	177.64	73.12
Prices/Earnings	23.19	51.17	41.54
Price/Sales	28.72	5.88	4.57
Price/FCF	142.94	177.64	73.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-1.22	0.13	0.13
Operating Margin	9.38	0.04	0.03
ROA	14.84	0.02	0.02
ROE	0.06	0.08	27.05
ROIC	0.04	0.06	42.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.01	0.05	-72.34
Dividends QOQ	1.00	-0.93	-7.47
EBIT QOQ	-0.29	0.07	-77.16
EPS QOQ	-0.26	-0.04	86.55
FCF QOQ	0.66	7.46	1021.60
Revenue QOQ	-0.27	< 0.005	-99.53
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.11	30.65	-4.53
Days Sales Outstanding (DSO)	3.96	3.97	0.37
Inventory Turnover	2.80	2.94	4.74
Debt/Capitalization	0.26	0.24	-8.50
Quick Ratio	0.55	0.40	-28.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	58.91	49.05	-16.75
Cash	40.25	25.90	-35.64
Capex	-2.34	-2.39	-2.10
Free Cash Flow	8.14	4.36	-46.37
Revenue	130.23	131.82	1.22
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.09	0.94	-13.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.86	-0.41	89.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating